![Matthew Kelly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Kelly
Corporate Officer/Principal en Perspectum Group Ltd. .
Cargos activos de Matthew Kelly
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Perspectum Group Ltd.
![]() Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01/10/2015 | - |
Historial de carrera de Matthew Kelly
Formación de Matthew Kelly.
The University of Manchester | Undergraduate Degree |
University of Cambridge | Doctorate Degree |
Estadísticas
Internacional
Reino Unido | 4 |
Operativa
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorial
Consumer Services | 3 |
Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Perspectum Group Ltd.
![]() Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Technology Services |
- Bolsa de valores
- Insiders
- Matthew Kelly
- Experiencia